Relcovaptan
Chemical compound
From Wikipedia, the free encyclopedia
Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist, selective for the V1A subtype.[1] It has shown positive initial results for the treatment of Raynaud syndrome and dysmenorrhoea, and as a tocolytic,[2] although it is not yet approved for clinical use.
Other names(2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide
ATC code
- none
| Clinical data | |
|---|---|
| Other names | (2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C28H27Cl2N3O7S |
| Molar mass | 620.50 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |